Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| CNCR (Loncar Cancer Immunotherapy ETF) | NA | -38.81% | -14.20% | -18.04% | NA | NA | NA | … | … |
Data as of 06/03/2025, Common starting date is 10/14/2015
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| CNCR (Loncar Cancer Immunotherapy ETF) | 10/14/2015 | 06/03/2025 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 0.00 | -38.81 | -14.20 | -18.04 | NA | NA | NA | … | … | -26.73 | -8.61 | -1.89 | -42.31 | -19.25 | 36.53 | 24.22 | -20.64 | 13.57 | -25.62 | 14.25 |
| Sharpe Ratio | NA | -1.07 | -0.49 | -0.57 | NA | NA | NA | … | … | -1.27 | -0.43 | -0.21 | -1.04 | -0.68 | 0.86 | 0.90 | -0.75 | 0.51 | -0.68 | 1.83 |
| Standard Deviation(%) | NA | 39.27 | 35.87 | 34.89 | NA | NA | NA | … | … | 43.96 | 35.35 | 29.88 | 41.98 | 28.17 | 41.79 | 25.38 | 29.51 | 25.46 | 37.82 | 47.03 |
| Draw Down(%) | NA | 50.28 | 55.45 | 75.85 | NA | NA | NA | … | … | 38.53 | 32.90 | 39.05 | 46.50 | 30.56 | 33.87 | 20.28 | 46.17 | 17.28 | 34.70 | 13.51 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 1.62 | 1.04 | 0.69 | 0.52 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 5.87 | 1.23 | 0.00 | 0.00 | 1.62 | 0.00 | 0.42 |
Data as of 06/03/2025, Common starting date is 10/14/2015
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| CNCR (Loncar Cancer Immunotherapy ETF) |
-28.24%
Nov 2020 – Nov 2023 |
-18.04%
May 2020 – May 2025 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| CNCR (Loncar Cancer Immunotherapy ETF) |
13.69%
Oct 2018 – Oct 2021 |
10.15%
Jan 2016 – Jan 2021 |
0.00%
NA |
0.00%
NA |
Annualized Rolling Returns Comparison Chart